Product Information
TRAZODONE 300 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.4977 per EA under NDC 60505265901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 25, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Apotex Corp.NDC
60505265901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071196FDA Approved
3/25/1987
TE Code
AB
On Market Since
1/5/2009
Pharmacological Classes
Price Statistics
The NADAC for TRAZODONE 300 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 81.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4977 per EA |
|---|---|
| All-time high | $3.7325 (Oct 12, 2016) |
| All-time low | $0.4977 (Sep 23, 2026) |
| 52-week high | $0.5876 |
| 52-week low | $0.4977 |
| Median price | $1.9898 |
| Average price | $1.9679 |
| Largest weekly change | +68.9% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trazodone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAZODONE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRAZODONE 300 MG TABLET, manufactured by Apotex Corp., is $0.4977 per EA (NDC 60505265901), effective Sep 30, 2026.
How has the price of TRAZODONE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRAZODONE 300 MG TABLET has declined 81.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRAZODONE 300 MG TABLET?
Since Nov 28, 2013, the NADAC for TRAZODONE 300 MG TABLET has ranged from a low of $0.4977 (Sep 23, 2026) to a high of $3.7325 (Oct 12, 2016), with a median of $1.9898 per EA.
Are there cheaper alternatives to TRAZODONE 300 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRAZODONE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRAZODONE 300 MG TABLET?
TRAZODONE 300 MG TABLET (NDC 60505265901) is labeled by Apotex Corp., and CMS classifies it as a generic product.